4.7 Article

Fluorescent Silicon Nanorods-Based Nanotheranostic Agents for Multimodal Imaging-Guided Photothermal Therapy

Journal

NANO-MICRO LETTERS
Volume 11, Issue 1, Pages -

Publisher

SHANGHAI JIAO TONG UNIV PRESS
DOI: 10.1007/s40820-019-0306-9

Keywords

Gold nanoparticle; Fluorescent silicon nanorods; Nanotheranostic; Multimodal imaging; Photothermal therapy; Tumor target

Funding

  1. National Basic Research Program of China (973 Program) [2013CB934400]
  2. National Natural Science Foundation of China [21825402, 31400860, 21575096, 21605109]
  3. Natural Science Foundation of Jiangsu Province of China [BK20170061]
  4. Collaborative Innovation Center of Suzhou Nano Science and Technology
  5. Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
  6. 111 Project
  7. Joint International Research Laboratory of Carbon-Based Functional Materials and Devices

Ask authors/readers for more resources

The utilization of diagnosis to guide/aid therapy procedures has shown great prospects in the era of personalized medicine along with the recognition of tumor heterogeneity and complexity. Herein, a kind of multifunctional silicon-based nanostructure, i.e., gold nanoparticles-decorated fluorescent silicon nanorods (Au@SiNRs), is fabricated and exploited for tumor-targeted multimodal imaging-guided photothermal therapy. In particular, the prepared Au@SiNRs feature high photothermal conversion efficiency (similar to 43.9%) and strong photothermal stability (photothermal performance stays constant after five-cycle NIR laser irradiation), making them high-performance agents for simultaneously photoacoustic and infrared thermal imaging. The Au@SiNRs are readily modified with targeting peptide ligands, enabling an enhanced tumor accumulation with a high value of similar to 8.74% ID g(-1). Taking advantages of these unique merits, the Au@SiNRs are superbly suitable for specifically ablating tumors in vivo without appreciable toxicity under the guidance of multimodal imaging. Typically, all the mice treated with the Au@SiNRs remain alive, and no distinct tumor recurrence is observed during 60-day investigation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available